Pulse nav.journalClub النقاشات النشطة الرائج استكشاف الباحثون

Join discussions, follow papers, and never miss your next session.

Download on theApp Store

الرئيسية استكشاف nav.journalClub الرائج

⌘+K

Randomized Double-blind Trial of Treatment of Vitiligo | Synapse

May 1, 2007

Randomized Double-blind Trial of Treatment of Vitiligo

Key Points

Key points are not available for this paper at this time.

Abstract

In the treatment of nonsegmental vitiligo, NB-UVB therapy is superior to oral PUVA therapy.

اسأل الذكاء الاصطناعي

Like

Bookmark

Share

اسأل الذكاء الاصطناعي

Like

Bookmark

Share

Cite This Study

Yones et al. (Tue,) studied this question.

synapsesocial.com/papers/69d8cc0817a1cc0598d187f5 https://doi.org/https://doi.org/10.1001/archderm.143.5.578

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Interventions for vitiligo: a Cochrane systematic review2006 · 28 citations
2Treatment of Vitiligo With UV-B Radiation vs Topical Psoralen Plus UV-A1997 · 350 citations
3British Photodermatology Group guidelines for PUVA1995 · 116 citations
4Reduced dermal infiltration of cytokine-expressing inflammatory cells in atopic dermatitis after short-term topical tacrolimus treatment2004 · 100 citations
5Psoralen–ultraviolet A <i>vs</i>. narrow‐band ultraviolet B phototherapy for the treatment of vitiligo2006 · 98 citations